These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 20729134

  • 1. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J, Pongsapich W, Mann SA, Hedrich J, Fruth K, Pogozelski B, Mann WJ.
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells.
    Brieger J, Mann SA, Pongsapich W, Koutsimpelas D, Fruth K, Mann WJ.
    Int J Mol Med; 2012 Mar; 29(3):505-9. PubMed ID: 22109647
    [Abstract] [Full Text] [Related]

  • 4. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C.
    Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391
    [Abstract] [Full Text] [Related]

  • 5. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jerónimo C, Henrique R, Nayak CS, Park HL, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA.
    Cancer Res; 2006 Oct 01; 66(19):9401-7. PubMed ID: 17018594
    [Abstract] [Full Text] [Related]

  • 6. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT.
    Oncogene; 2002 Jun 20; 21(27):4231-6. PubMed ID: 12082610
    [Abstract] [Full Text] [Related]

  • 7. FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.
    Venza I, Visalli M, Tripodo B, De Grazia G, Loddo S, Teti D, Venza M.
    Br J Dermatol; 2010 May 20; 162(5):1093-7. PubMed ID: 19845668
    [Abstract] [Full Text] [Related]

  • 8. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z.
    Cancer Lett; 2005 Dec 18; 230(2):271-83. PubMed ID: 16297713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
    Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK, Dent SY.
    Oncogene; 2003 Dec 04; 22(55):8902-11. PubMed ID: 14654786
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P.
    Oncogene; 2012 Dec 06; 31(49):5108-16. PubMed ID: 22286769
    [Abstract] [Full Text] [Related]

  • 12. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS, Carvalho AL, Jeronimo C, Henrique R, Kim MM, Hoque MO, Chang S, Jiang WW, Koch W, Westra W, Sidransky D, Califano J.
    Laryngoscope; 2007 Aug 06; 117(8):1376-80. PubMed ID: 17592394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW, Cui YT, Zhong RR, Liang DC, Liu YM, Wang YG, He Z, Wang S, Liang SJ, Zhang P.
    Clin Lab; 2012 Aug 06; 58(1-2):41-51. PubMed ID: 22372344
    [Abstract] [Full Text] [Related]

  • 15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 06; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 16. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C, Tannapfel A.
    Oncogene; 2005 Oct 06; 24(44):6699-708. PubMed ID: 16007169
    [Abstract] [Full Text] [Related]

  • 17. Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols.
    Paluszczak J, Krajka-Kuźniak V, Małecka Z, Jarmuż M, Kostrzewska-Poczekaj M, Grenman R, Baer-Dubowska W.
    Toxicol In Vitro; 2011 Feb 06; 25(1):213-21. PubMed ID: 21078381
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic inactivation of RASSF1A in head and neck cancer.
    Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3635-40. PubMed ID: 14506151
    [Abstract] [Full Text] [Related]

  • 19. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 01; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

  • 20. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
    Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA.
    PLoS One; 2012 Feb 01; 7(9):e45534. PubMed ID: 23029077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.